ATH
vs
AMGN
ATH
AMGN
Over the past 12 months, ATH has underperformed AMGN, delivering a return of -33% compared to the AMGN's +24% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ATH
AMGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Alterity Therapeutics Ltd
ASX:ATH
|
0.008
AUD
|
|||||
|
Amgen Inc
NASDAQ:AMGN
|
367.05
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ATH, AMGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Alterity Therapeutics Ltd
Revenue
|
|||||||||||
|
Amgen Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ATH, AMGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Alterity Therapeutics Ltd
ASX:ATH
|
|||||||||
|
Amgen Inc
NASDAQ:AMGN
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Alterity Therapeutics Ltd | ||||
|
Amgen Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ATH, AMGN
Performance By Year
ATH, AMGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.